Cmps stock forecast.

Compare to Open 5.75 Prior Close 5.66 (11/16/23) 1 Day CMPS 6.18% DJIA 0.01% Russell 2K 1.35% Health Care/Life Sciences -0.07% Overview Per-Share Earnings, Actuals & Estimates COMPASS Pathways...

Cmps stock forecast. Things To Know About Cmps stock forecast.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comPLAN Stock 12 Months Forecast. $65.10. (2.15% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Anaplan in the last 3 months. The average price target is $65.10 with a high forecast of $66.00 and a low forecast of $63.75. The average price target represents a 2.15% change from the last price of $63.73.View the CMPS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Compass Pathways Plc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on …25 нояб. 2023 г. ... ... stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility ...

Nov 27, 2023 · CMPS Signals & Forecast. The Compass Pathways PLC stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. View the CMPS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Compass Pathways Plc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on …The current average CMPS price target, as estimated by these analysts, is $0.00. The predictions for the future CMPS stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CMPS.

These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, ... Wall Street’s 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS)

Nov 13, 2023 · Future criteria checks 0/6. COMPASS Pathways's earnings are forecast to decline at 2.7% per annum while its annual revenue is expected to grow at 82.4% per year. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be -82.5% in 3 years. The current average CMPS price target, as estimated by these analysts, is $0.00. The predictions for the future CMPS stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CMPS. COMPASS Pathways PLC (CMPS) stock is down -1.77% while the S&P 500 is higher by 1.89% as of 2:59 PM on Thursday, Apr 27. CMPS has fallen -$0.15 from the previous closing price of $8.17 on volume of 236,713 shares. Over the past year the S&P 500 has fallen -1.22% while CMPS has fallen -21.27%.Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Based on analysts offering 12 month price targets for CMPS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Nov 29, 2023 · Analyst Forecast. According to 5 analysts, the average rating for CMPS stock is "Strong Buy." The 12-month stock price forecast is $49.6, which is an increase of 736.43% from the latest price.

According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Find the latest COMPASS Pathways Plc - American CMPS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating ... Apr 26, 2021 · CMPS Stock Price Forecast. Long-term, we love COMPASS Pathways. The Shroom Boom is the next big investment megatrend in the healthcare/biotech sector. COMPASS Pathways is the leading company in ... Get the LIVE share price of COMPASS Pathways PLC(CMPS) and stock performance in one place to strengthen your trading strategy in US stocks.Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis.

Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis. Dec 1, 2023 · Based on short-term price targets offered by 40 analysts, the average price target for Amazon comes to $170.90. The forecasts range from a low of $123.00 to a high of $210.00. The average price ... COMPASS Pathways PLC ADR (CMPS) Company Bio. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and ...Farfetch Ltd (NYSE:FTCH) posted its quarterly earnings results on Thursday, November, 18th. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.48. The business had revenue of $582.57 million for the quarter, compared to analyst estimates of $591.34 million.Find real-time DXCM - Dexcom Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.37: Annual revenue (last year) $2.9B: Annual profit (last year)7 июн. 2023 г. ... COMPASS Pathways Plc American Depository Shares, CMPS stock forecast, stock analysis, stock rating, stock news, share price, ...A high-level overview of COMPASS Pathways plc (CMPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

GGB Earnings Forecast. Next quarter’s earnings estimate for GGB is $0.17 with a range of $0.14 to $0.20. The previous quarter’s EPS was $0.19. GGB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.34% of the time in the same period.

You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CMPS scored across 33 valuation, financial, forecast, performance, and dividend due ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The ...The head of COMPASS Pathways (CMPS) contended that investors should keep in mind the positive results displayed in a recent clinical trial of its psychedelics-based treatment for depression.3 brokers have issued 1 year price objectives for Cybin's stock. Their CYBN share price targets range from $3.00 to $10.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 1,184.2% from the stock's current price. View analysts price targets for CYBN or view top ...The average Dexcom stock price prediction forecasts a potential upside of 14.98% from the current DXCM share price of $116.18. What is DXCM's forecast return on ... Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, ... EPS forecast (this quarter)-$0.07: Annual revenue (last year) $477.7M: Annual profit (last year)Nikkei 225. 30,696.96. -0.95%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Compass Pathways PLC (CMPS.OQ) real-time stock quotes, news, price and financial information from ...The Fed will hike rates by 25 basis points next month, S&P Global Ratings forecast. That's as falling Treasury yields are no longer a constraint on financial conditions.

The Estée Lauder Companies (EL) Stock Forecast & Price Target

Compass Pathways Plc - ADR Stock Chart and Share Price Forecast, Short-Term "CMPS" Stock Prediction for Next Days and Weeks Walletinvestor.com Compass Pathways Plc - ADR (CMPS) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

View the latest Stemtech Corp. (STEK) stock price, news, historical charts, analyst ratings and financial information from WSJ.COMPASS Pathways PLC (CMPS) stock is down -1.77% while the S&P 500 is higher by 1.89% as of 2:59 PM on Thursday, Apr 27. CMPS has fallen -$0.15 from the previous closing price of $8.17 on volume of 236,713 shares. Over the past year the S&P 500 has fallen -1.22% while CMPS has fallen -21.27%.COMPASS Pathways Stock Forecast All Analysts Top Analysts Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for …See COMPASS Pathways plc (CMPS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...Nov 5, 2023 · Just two days after my note was published, CMPS announced a major capital raise; the news triggered a nice bounce in the price, with the stock up by ~20% on the day of the release. My Sell call at ... COMPASS Pathways PLC ADR (CMPS) Company Bio. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and ...Compass Pathways (CMPS-6.05%) is not your typical healthcare company. The London-based clinical-stage biopharma is developing therapies for various forms of depression that center around ...AURA. Aura Biosciences Inc. 8.03. UNCH. UNCH. Get Compass Pathways PLC (CMPS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest COMPASS Pathways plc (CMPS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Market Q&A Comments Buy CRYPTO Select other stock... Current Price 6.450 USD 7 Days Forecast Get It Now! 1-Year Forecast * 0.244 USD Historical index on US Stock …The latest COMPASS Pathways stock prices, stock quotes, news, and CMPS history to help you invest and trade smarter. ... COMPASS Pathways Stock Snapshot. 13.44 Bid. 100.00 ... Instagram:https://instagram. day trading websiteslemonade landlord insurancenike store chinatd ameritrade alternative According to . 14 Wall Street analysts that have issued a 1 year FANG price target, the average FANG price target is $188.57, with the highest FANG stock price forecast at $225.00 and the lowest FANG stock price forecast at $154.00.7 июн. 2023 г. ... COMPASS Pathways Plc American Depository Shares, CMPS stock forecast, stock analysis, stock rating, stock news, share price, ... headless cms market sizeetf broker Future criteria checks 0/6. COMPASS Pathways's earnings are forecast to decline at 2.7% per annum while its annual revenue is expected to grow at 82.4% per year. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be -82.5% in 3 years.Find real-time CF - CF Industries Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. lincoln 2009 penny COMPASS Pathways. Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies, and are pioneering ... Find real-time MRVL - Marvell Technology Inc stock quotes, company profile, news and forecasts from CNN Business.CMPS Earnings Date and Information. COMPASS Pathways last posted its quarterly earnings results on November 2nd, 2023. The reported ($0.67) EPS for the quarter, missing the consensus estimate of ($0.50) by $0.17. COMPASS Pathways has generated ($2.59) earnings per share over the last year ( ($2.59) diluted earnings per share).